SEC Tracker
Get the app

Zymeworks ZYME

Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Zymeworks files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Anaptysbio ANAB public float $633M, Dec 31, 2025
  2. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025
  3. ImmunityBio IBRX public float $690M, Jun 30, 2025
  4. Evoke Pharma EVOK
  5. Anavex Life Sciences AVXL public float $708M, Mar 31, 2025, over 18 months old

Data on this page was fetched . The filing on SEC.gov is the record.